Search Results
The I-PASS Study aims to implement a standardized, evidence-based handoff program comprised of the innovative I-PASS Handoff Bundle (including team training, a verbal mnemonic, and a structured printed tool) and to rigorously measure its impact on …
We are a multi-national team dedicated to the understanding and treatment of obesity and obesity-related diseases. Our laboratory is located within the Division of Endocrinology , Boston Children’s Hospital, Harvard Medical School. The primary aim of …
Our research One of the major players in innate immune system is neutrophil which is the most abundant cell type among circulating white blood cells and constitutes the first line of host defense against invading bacteria and other pathogens. The …
Our mission is to develop and implement Natural Language Processing (NLP) technologies to apply to the electronic medical record. These technologies include core NLP tasks such as relation extraction, coreference resolution, and parsing, and make use of …
A biomarker is an objective sign that indicates the presence of disease arising from pathogenic biologic processes; this is distinct from a symptom, which is an indicator of illness perceived by a patient. Current methods of diagnosis and treatment for …
Currently, we do not know exactly what causes children or adults to develop congenital heart disease (CHD). Previous research suggests that there are both genetic and environmental factors that contribute to the development of CHD. Congenital heart …
The Sports Medicine Research Laboratory, led by principal investigator Dr. Martha M. Murray, focuses on sports medicine injuries, including those of the anterior cruciate ligament (ACL), knee meniscus and articular cartilage. In conjunction with our …
Leonard Zon's laboratory focuses on the use of the zebrafish model for research into hematopoiesis and as a screen for oncogenic genes and proteins. Each day, humans require the production of about one hundred billion new blood cells for proper …
The primary focus of the Laboratory for Neuroinformatics is to develop new computational methods for extracting digital biomarkers for brain disorders from EEG measurements. Our approach to EEG signal analysis is based in complex dynamical systems …
The primary aims of our laboratory are: to identify and characterize risk genes for psychotic and affective disorders and related conditions and to specify genetic influences on normal variation of in-vivo measures of brain structure and function and …